Novo Nordisk: Difference between revisions

Line 97: Line 97:


==Toxicogenomics==
==Toxicogenomics==
Novo Nordisk is involved in government funded collaborative research projects with other industrial and governmental partners. One example in the area of [[Pre-clinical development|non-clinical]] safety assessment is the InnoMed PredTox. The company is expanding its activities in joint research projects within the framework of the [[Innovative Medicines Initiative]] of [[European Federation of Pharmaceutical Industries and Associations]] and the [[European Commission]].
Novo Nordiskは、他の産業界や政府パートナーとの政府資金による共同研究プロジェクトに関与している。[[Pre-clinical development/ja|非臨床]]安全性評価の分野では、InnoMed PredToxがその一例である。同社は[[:en:European Federation of Pharmaceutical Industries and Associations|欧州製薬団体連合会]][[:en:European Commission|欧州委員会]]の[[:en:Innovative Medicines Initiative|革新的医薬品イニシアティブ]]の枠組みの中で共同研究プロジェクトの活動を拡大している。
 
==Diabetic work==
==Diabetic work==
[[Image:Novo Nordisk Kalundborg 20130729 003 (9720766202).jpg|thumb|right|upright|Novo Nordisk's largest manufacturing plant located in [[Kalundborg]], Denmark]]
[[Image:Novo Nordisk Kalundborg 20130729 003 (9720766202).jpg|thumb|right|upright|Novo Nordisk's largest manufacturing plant located in [[Kalundborg]], Denmark]]